Compare Tyche Industries with Similar Stocks
Dashboard
The company is Net-Debt Free
Poor long term growth as Net Sales has grown by an annual rate of -7.27% and Operating profit at -59.51% over the last 5 years
The company has declared Negative results for the last 5 consecutive quarters
With ROE of 4.9, it has a Very Expensive valuation with a 0.9 Price to Book Value
Majority shareholders : Promoters
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Pharmaceuticals & Biotechnology
INR 135 Cr (Micro Cap)
19.00
45
2.37%
-0.54
4.93%
0.92
Total Returns (Price + Dividend) 
Latest dividend: 3 per share ex-dividend date: Sep-19-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Tyche Industries Ltd Upgraded to Hold as Technicals Improve Despite Financial Challenges
Tyche Industries Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 22 June 2026. This change reflects a nuanced assessment of the company’s technical indicators, valuation, financial trends, and overall quality, signalling cautious optimism amid ongoing operational headwinds.
Read full news article
Tyche Industries Ltd is Rated Sell
Tyche Industries Ltd is rated Sell by MarketsMOJO, with this rating last updated on 3 June 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 16 June 2026, providing investors with the latest insights into its performance and outlook.
Read full news article
Tyche Industries Ltd Upgraded to Sell: Financial and Technical Analysis
Tyche Industries Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Strong Sell to Sell as of 3 June 2026. This change reflects a nuanced improvement in the company’s financial trend and a shift in technical indicators, despite ongoing challenges in valuation and quality metrics.
Read full news article Announcements 
Closure of Trading Window
24-Jun-2026 | Source : BSEThe trading window of the Company shall remain closed w.e.f July 1 2026 till the expiry of 48 hours after the declaration of Un-Audited Financial results of the Company for the quarter and three Months ended June 30 2026.
Announcement under Regulation 30 (LODR)-Newspaper Publication
31-May-2026 | Source : BSENewspaper Publication og Audited Financial Results for the 4th Quarter and Year Ended March 31 2026
Compliances-Reg.24(A)-Annual Secretarial Compliance
29-May-2026 | Source : BSEPursuant to Regulation 24A of SEBI(LODR) Regulations 2015 please find enclosed herewith the Annual Secretarial Compliance Report for the Year ended March 31 2026.
Corporate Actions 
No Upcoming Board Meetings
Tyche Industries Ltd has declared 30% dividend, ex-date: 19 Sep 25
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Silver Oak Technologies Private Limited (19.31%)
Plutus Techlabs Private Limited (6.4%)
26.55%
Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ
QoQ Growth in quarter ended Mar 2026 is 53.12% vs -25.28% in Dec 2025
QoQ Growth in quarter ended Mar 2026 is -36.81% vs 19.74% in Dec 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is -25.51% vs 8.98% in Sep 2024
Growth in half year ended Sep 2025 is -41.22% vs 14.87% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is -30.42% vs -2.71% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -49.65% vs 13.02% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is -18.08% vs -5.81% in Mar 2025
YoY Growth in year ended Mar 2026 is -44.08% vs 1.39% in Mar 2025






